The potential underlying reasons for the significant decrease in these GFAPlowAQP4+CD63+ astrocytes in AD include the possibility that the GFAPlow astrocytes near the plaques may senesce within the AD brain. This evidence concerns the gene CD63 and Alzheimer disease.